MPV

Mean Platelet Volume

Complete Blood Count

What is Mean Platelet Volume?

Mean platelet volume (MPV) measures the average size of platelets in your blood and is reported in femtoliters (fL). Platelets are small, disc-shaped cell fragments produced by megakaryocytes in the bone marrow, and their size at the time of release is related to how actively the bone marrow is producing them. Younger, newly released platelets tend to be larger and more metabolically active than older, circulating platelets. Therefore, MPV serves as an indirect measure of thrombopoiesis—the rate and activity of platelet production by the bone marrow.

MPV is automatically measured by modern hematology analyzers as part of a CBC, though it is not always reported or reviewed unless specifically requested. The clinical utility of MPV has grown significantly in recent years, as research has linked MPV to a wide range of conditions beyond hematology, including cardiovascular disease, inflammatory disorders, and metabolic syndrome. MPV must be interpreted in conjunction with the platelet count—the combination reveals whether the bone marrow is compensating for increased platelet destruction (high MPV with low platelet count) or if there is a primary production problem (low MPV with low platelet count).

Why It Matters

MPV provides a window into bone marrow platelet production activity. A high MPV with low platelet count (as seen in immune thrombocytopenia or ITP) indicates that the bone marrow is responding to peripheral platelet destruction by releasing young, large platelets—a compensatory response. A low MPV with low platelet count suggests the bone marrow itself is failing (aplastic anemia, chemotherapy effect). Beyond hematology, elevated MPV has been associated with increased cardiovascular risk—larger platelets are more reactive, contain more granules, and form clots more readily. MPV may also serve as an inflammatory marker, as it changes in response to chronic inflammation.

Normal Reference Ranges

GroupRangeUnit
Adults7.5–11.5fL
Children7.0–11.0fL

Reference ranges may vary by laboratory. Always compare results to the ranges provided by your testing facility.

What High MPV Levels Mean

Common Causes

  • Immune thrombocytopenic purpura (ITP)—compensatory large platelet production
  • Myeloproliferative disorders (essential thrombocythemia, polycythemia vera)
  • Cardiovascular disease and acute coronary syndromes
  • Hyperthyroidism
  • Diabetes mellitus and metabolic syndrome

Possible Symptoms

  • Easy bruising or petechiae (if platelet count is also low)
  • Mucosal bleeding (nosebleeds, gum bleeding)
  • Symptoms may be absent when platelet count is normal or elevated
  • Symptoms of the underlying condition (chest pain in cardiovascular disease, etc.)

What to do: Elevated MPV should be interpreted alongside the platelet count. If the platelet count is low, consider destructive thrombocytopenias (ITP, TTP) where the bone marrow compensates with larger platelets. A peripheral blood smear can confirm the presence of giant platelets and rule out platelet clumping (pseudothrombocytopenia). If the platelet count is normal or high with elevated MPV, consider myeloproliferative disorders or cardiovascular risk assessment. Evaluation may include antiplatelet antibodies, bone marrow evaluation, or cardiovascular workup depending on the clinical picture.

What Low MPV Levels Mean

Common Causes

  • Aplastic anemia or bone marrow suppression
  • Chemotherapy or radiation therapy effects on bone marrow
  • Wiskott-Aldrich syndrome (rare genetic condition with small platelets)
  • Hypersplenism (spleen sequesters and destroys platelets)
  • Sepsis and disseminated intravascular coagulation (DIC)

Possible Symptoms

  • Excessive bleeding from minor cuts or procedures
  • Easy bruising
  • Heavy menstrual bleeding
  • Petechiae (small red or purple spots on the skin)

What to do: Low MPV with low platelet count suggests a bone marrow production problem and may warrant bone marrow biopsy to assess megakaryocyte number and morphology. Review medications for bone marrow suppressants. If splenomegaly is present, consider hypersplenism with imaging and hepatology consultation. In the setting of sepsis, check for DIC with coagulation studies (PT, aPTT, D-dimer, fibrinogen). Wiskott-Aldrich syndrome should be considered in male children with small platelets, eczema, and immunodeficiency.

When Is MPV Testing Recommended?

  • As part of a routine CBC (automatically calculated by most analyzers)
  • When evaluating thrombocytopenia to distinguish destructive from productive causes
  • When investigating myeloproliferative disorders
  • When assessing cardiovascular risk factors

Frequently Asked Questions

Multiple studies have found that elevated MPV is associated with increased cardiovascular risk. Larger platelets are more reactive—they aggregate more readily, produce more thromboxane A2, express more glycoprotein IIb/IIIa receptors, and release more prothrombotic and proinflammatory mediators. This hyperreactivity contributes to thrombus formation. Elevated MPV has been linked to acute myocardial infarction, stroke, and poor outcomes after coronary interventions. Some researchers have proposed MPV as an independent cardiovascular risk factor. However, MPV is not yet part of standard cardiovascular risk assessment algorithms, partly due to variability in measurement methods and lack of standardized reference ranges across laboratories.
When platelet counts are low, MPV helps determine whether the problem lies in destruction or production. In destructive thrombocytopenias (ITP, TTP, DIC), the bone marrow receives signals to increase platelet production. Megakaryocytes enlarge and shed bigger, more active platelets, resulting in a high MPV despite a low count. In productive thrombocytopenias (aplastic anemia, bone marrow failure, chemotherapy), the marrow cannot respond adequately, so the few platelets produced are small or normal-sized, resulting in a low or normal MPV with a low count. This distinction helps guide diagnostic workup and avoids unnecessary bone marrow biopsies when a destructive cause is likely.
Yes, MPV is significantly affected by the anticoagulant used in the collection tube and the time between blood draw and analysis. In EDTA tubes (the standard purple-top tube), platelets swell over time as they absorb water, causing MPV to increase progressively—by 7–13% within the first 2 hours and continuing to rise for up to 24 hours. For accurate MPV measurement, samples should ideally be analyzed within 1–2 hours of collection. Some laboratories use citrate tubes for MPV, which show more stable results. This pre-analytical variability is one reason MPV is not yet standardized across laboratories and may limit its clinical application.

Related Biomarkers

Want your MPV levels analyzed?

Upload your lab results for an instant AI-powered breakdown of all your biomarkers.

Upload Lab Results →

Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Reference ranges may vary between laboratories. Always consult your healthcare provider for interpretation of your specific test results.

Disclaimer: SymptomGPT is not a medical diagnosis tool and does not provide medical advice. Always consult a qualified healthcare professional. If you are experiencing a medical emergency, call 911 immediately.